Una Uma proposta para o desenho e a implementação de propostas de valor em medicamentos de alto custo

  • Flavio Adrian Alvarez Facultad de Ciencias Económicas-UBA
Palavras-chave: Proposta de valor; desenho; implementação; medicamentos de alto custo; Argentina

Resumo

O setor de medicamentos de alto custo é muito importante no mercado farmacêutico argentino, porque representa 20% do faturamento do setor (Comisión Nacional de Defensa de la Competencia, 2019).

Ter uma proposta de valor que explique claramente quais são os diferenciais desses medicamentos é fundamental, pois a sua compra é analisada detalhadamente pelos auditores das financiadoras (empresas de medicina de grupo, obras sociais e governo). Isso se deve ao seu alto custo (seu preço representa mais de 40% da renda mensal de uma família) e à severidade das doenças (Marín & Polach, 2011).

Acreditamos que este artigo preenche uma lacuna nesse aspecto, visto que não é um assunto tratado na literatura. Essa metodologia tem um olhar prático sobre o assunto e pode ser aplicado no gerenciamento desse tipo de medicamento.

Os principais passos propostos são decidir se vale a pena implementar uma abordagem ressonante, determinar o valor por stakeholders-chave, segmentar e escolher os principais stakeholders, definir e testar a proposta de valor, combinar recursos com a proposta de valor, desenhar a comunicação e realinhar.

Downloads

Não há dados estatísticos.

Referências

Anderson, J. C., Kumar, N., & Narus, J. A. (2007). Value merchants: Demonstrating and documenting superior value in business markets. Harvard Business School Press.
Barnes, C., Blake, H., & Pinder, D. (2009). Creating & delivering your value proposition: Managing customer experience for profit. Kogan Page.
Barney, J. B., & Clark, D. N. (2007). Resource-based theory: Creating and sustaining competitive advantage. Oxford University Press.
Comisión Nacional de Defensa de la Competencia. (2019). Informe técnico sobre las condiciones de competencia en el mercado de medicamentos. Comisión Nacional de Defensa de la Competencia.
Deloitte AG. (2021). Commercializing specialty pharmaceuticals: Raising the game on channel strategy and analytics (p. 15). Deloitte AG.
Dennis, L. D. (2018). Value Propositions That Sell: Turning your message into a magnet that attracts buyers. Mind Your Business Press.
Eyal, N., & Hoover, R. (2013). Hooked: How to build habit-forming products (Revised and updated). Portfolio/Penguin.
Giacosa, L., & Sgattoni, M. (2021, mayo). Segmentación y Targeting en la era digital: De lo tradicional al Machine Learning.
Gourville, J. T. (2006). Eager Sellers and Stony Buyers. Harvard Business Review, June, 10.
Henson, K. (2021, mayo 6). Patient Services Are Simplifying the Healthcare Consumer Experience. Pharmaceutical Executive. 02/09/2022. https://www.pharmexec.com/view/patient-services-are-simplifying-the-healthcare-consumer-experience
Kim, J., Combs, K., Downs, J., & Tillman, F. I. (2018). Medication Adherence: The Elephant in the Room. Medication Management, 43(1), 30-34.
Lanning, M. J. (1998). Delivering profitable value: A revolutionary framework to accelerate growth, generate wealth, and rediscover the heart of business. Perseus Books.
Lanning, M. J., & Michaels, E. J. (1988). A Business is a Value Delivery System. McKinsey Staff Paper, 41, 1-16.
Marín, G. H., & Polach, M. A. (2011). Medicamentos de alto costo: Análisis y propuestas para los países del Mercosur. Rev Panam Salud Publica, 30(2), 167-176.
McKinsey & Co. (2013). Insights into pharmaceuticals products: Launch excellence (Pharmaceutical and Medical Products Practice 2013, p. 74) [Insights]. McKinsey & Co.
McKinsey & Co. (2018). From product to customer experience: The new way to launch in pharma (McKinsey Pharmaceuticals & Medical Products (PMP), p. 11). McKinsey & Co.
Moore, G. A. (2006). Crossing the chasm: Marketing and selling disruptive products to mainstream customers (rev. ed., first Collins business essentials ed). Collins Business Essentials.
Osterwalder, A., Pigneur, Y., Bernarda, G., & Smith, A. (2014). Value proposition design: How to create products and services customers want. John Wiley & Sons.
Osterwalder, A., Pigneur, Y., & Clark, T. (2010). Business model generation: A handbook for visionaries, game changers, and challengers. Wiley.
Payne, A., Frow, P., Steinhoff, L., & Eggert, A. (2020). Toward a comprehensive framework of value proposition development: From strategy to implementation. Industrial Marketing Management, 87, 244-255. https://doi.org/10.1016/j.indmarman.2020.02.015
Revella, A. (2015). Buyer personas: How to gain insight into your customer’s expectations, align your marketing strategies, and win more business. Wiley.
Savage, G. T., Nix, T. W., Whitehead, C. J., & Blair, J. D. (1991). Strategies for assessing and managing organizational stakeholders. Academy of Management Perspectives, 5(2), 61-75. https://doi.org/10.5465/ame.1991.4274682
Somsel, T. (2021, noviembre 3). Winning with evidence: Develop and deliver differentiated value propositions [Webinar]. Reuters events.
Urbany, J. E., & Davis, J. H. (2010). Grow by focusing on what matters: Competitive strategy in 3 circles: 3-circle growth (First edition). Business Expert Press.
Vanderveer, R., & Pines, N. (2007). Customer-Driven Positioning: The Next Generation Approach to Pharmaceutical Product Positioning. Journal of Medical Marketing, 7, 71-76. https://doi.org/10.1057/palgrave.jmm.5050066
Wenzel, M. (2017, febrero 21). How to ensure commercial success through early value definition. executive insights HEALTHCARE CONSULTANTS - Publications. https://www.executiveinsight.ch/en/insights/publications?myfilterID=blockID%3D2786%26pageID%3D204%26akID%255B46%255D%255BatSelectOptionID%255D%255B%255D%3D2%26akID%255B46%255D%255BatSelectOptionID%255D%255B%255D%3D4&ccm_paging_p=3
Wilson, J., & Shah, S. (2015). Pharma Market Access Success: GLOBALHealthPR, May, 8.
Publicado
2022-12-01
Como Citar
Alvarez, F. A. (2022). Una Uma proposta para o desenho e a implementação de propostas de valor em medicamentos de alto custo. Revista De Negócios E Ciências Sociais, 8(5), 66-101. Recuperado de https://publicacionescientificas.uces.edu.ar/index.php/empresarialesysociales/article/view/1459